Saturday, July 11, 2026
🇺🇸 FDA

Drug profile · INN

clostridium

clostridium is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 20
Pipeline programs 17
News articles 0
Drug details — clostridium
Class
—
Route
—
Patents
20
Programs
17
Data quality
0.70
← All drugs Related patents Pipeline programs Drug news hub Event calendar

Quick answer

clostridium is an FDA-listed pharmaceutical active ingredient.

Key facts

INN clostridium

Approval history

Authority Status Date
NMPA clinical trials —

Pipeline programs

Browse pipeline
  1. M602011084 Phase 3 · Merz Therapeutics · Chronic migraine
  2. M602011085 Phase 3 · Merz Therapeutics · Episodic migraine
  3. SER-109 Phase 3 · Seres Therapeutics · Clostridium Difficile Infection
  4. CP101 Phase 2 · Finch Therapeutics Group · Clostridium Difficile Infection
  5. Clostridium Butyricum Tablets Phase 2 · First People's Hospital · Bladder (Urothelial, Transitional Cell) Cancer
  6. Full Spectrum Microbiota Phase 2 · Finch Therapeutics Group · Clostridium Difficile Infection Recurrence
  7. Ibezapolstat Phase 2 · Acurx Pharmaceuticals · Clostridium Difficile Infection
  8. Ibezapolstat Phase 2 · Acurx Pharmaceuticals · Clostridium Difficile Infection Recurrence

Related patents

Browse patents

  1. US 12390496

    Methods for treating ulcerative colitis

    Expires Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 2025235515

    CLOSTRIDIUM BOTULINUM NEUROTOXIN SEROTYPE A COMPOSITIONS AND IMPROVED DRYING PROCESSES

    Expires Wed Jul 19 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. WO 2025111258

    COMPOSITIONS DE SÉROTYPE A DE NEUROTOXINE DE CLOSTRIDIUM BOTULINUM ET PROCÉDÉS DE FILTRATION AMÉLIORÉS

    Expires Thu May 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12285447

    Methods and compositions for treating ulcerative colitis

    Expires Mon Apr 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12144800

    Inhibiting germination of Clostridium perfringens spores to reduce necrotic enteritis

    Expires Mon Nov 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12036225

    Use of ibezapolstat to promote microbiome health

    Expires Mon Jul 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11865145

    Compositions and methods for maintaining and restoring a healthy gut barrier

    Expires Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11857629

    Methods and compositions for self-regulated release of active pharmaceutical ingredient

    Expires Mon Dec 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 11730775

    Methods for treatment of Clostridium difficile infection or recurrence or symptoms thereof

    Expires Mon Aug 17 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 11723885

    Methods and compositions for interfering with extraction or conversion of a drug susceptible to abuse

    Expires Mon Aug 10 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 11623930

    Imidazodiazepinediones and methods of use thereof

    Expires Mon Apr 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 11554114

    Methods and compositions for self-regulated release of active pharmaceutical ingredients

    Expires Mon Jan 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 11197837

    Methods and compositions for interfering with extraction or conversion of a drug susceptible to abuse

    Expires Mon Dec 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 11166990

    Methods and compositions for treating ulcerative colitis

    Expires Mon Nov 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 11118170

    Engineered clostridium botulinum toxin adapted to deliver molecules into selected cells

    Expires Mon Sep 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 11103581

    Methods and compositions for self-regulated release of active pharmaceutical ingredient

    Expires Mon Aug 26 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 11083794

    Methods and compositions for self-regulated release of active pharmaceutical ingredient

    Expires Mon Aug 05 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 11071759

    Methods for treating ulcerative colitis

    Expires Mon Jul 22 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 11046690

    Pyridazinones and methods of use thereof

    Expires Mon Jun 24 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 10945996

    Inhibiting germination of clostridium perfringens spores to reduce necrotic enteritis

    Expires Mon Mar 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is clostridium?

clostridium is an FDA-listed pharmaceutical active ingredient.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.